Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220501054718N1Phase 3Completed
Phase 3, single-blind trial of midazolam (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: Maternal hemodynamic factors, Neonatal Apgar score at 1 minute and 1 more. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220501054718N1.